PSY - Defiance Next Gen Altered Experience ETF (USD) (US26922B8081)

The Defiance Next Gen Altered Experience ETF seeks to track the BITA Medical Psychedelics, Cannabis, and Ketamine Index, a rules-based index that tracks the performance of a portfolio of companies listed on North American operating in medical psychedelics, medical cannabis industries, production of cannabis pharmaceuticals and cannabidiol (“CBD”) derivatives, and ketamine.

The Defiance Next Gen Altered Experience ETF (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in North America. The Defiance ETFs fund’s base currency is USD and the share class was registered 27.05.2021 with unique ISIN - US26922B8081. Main exchange is NYSE Arca and ticker symbol is PSY. The total expense ratio is 0.75%. The Defiance Next Gen Altered Experience ETF (USD) pays dividends 1 time(s) per year.